Clinical Trials on Malignant Solid Neoplasm in New Zealand
Total 16923 results
-
Memorial Sloan Kettering Cancer CenterRecruitingMalignant Pleural MesotheliomaUnited States
-
Georgetown UniversityOregon Health and Science University; Tesaro, Inc.TerminatedHomologous Recombination Deficiency | Solid Tumor, AdultUnited States
-
Clarity Pharmaceuticals LtdCompletedBiochemical Recurrence of Malignant Neoplasm of ProstateUnited States
-
Novartis PharmaceuticalsTerminatedSolid TumorsUnited States, Taiwan, Spain, Canada, Italy, Singapore, Japan, Hong Kong
-
Memorial Sloan Kettering Cancer CenterAtara BiotherapeuticsRecruitingMalignant Pleural Mesothelioma (MPM)United States
-
Roswell Park Cancer InstituteCompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Weill Medical College of Cornell UniversityCelgene CorporationCompletedEsophageal Cancer | Malignant Neoplasm of Cardio-esophageal Junction of StomachUnited States
-
Louisiana State University Health Sciences Center...UnknownMalignant MesotheliomaUnited States
-
Y Biologics Inc.Novotech (Australia) Pty LimitedActive, not recruitingAdvanced Solid TumorsKorea, Republic of, Thailand, Australia
-
Hoffmann-La RocheCompletedAdvanced Solid TumorsUnited States, France
-
Taiho Oncology, Inc.TerminatedAdvanced Solid TumorsUnited States
-
Geneos TherapeuticsActive, not recruitingHCCUnited States, New Zealand
-
Gilead SciencesRecruitingSolid TumorsAustralia, United States, Canada
-
Eisai Inc.Completed
-
Memorial Sloan Kettering Cancer CenterWithdrawnMalignant Pleural MesotheliomaUnited States
-
GenmabBioNTech SEActive, not recruitingSolid Tumor, AdultSpain, United States
-
Gilead SciencesTerminatedAdvanced Solid TumorsUnited States
-
Neurological Surgery, P.C.TerminatedRecurrent Malignant GliomasUnited States
-
Incyte CorporationTerminatedSolid Tumors and Hematologic MalignancyUnited States, Netherlands, Belgium
-
Xilio Development, Inc.Recruiting
-
Genentech, Inc.CompletedSolid TumorUnited States, Korea, Republic of, Spain, France
-
Galvanize Therapeutics, Inc.RecruitingLung Neoplasm MalignantUnited States
-
Agenus Inc.Terminated
-
National Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
AmgenRecruitingAdvanced Solid TumorsUnited States, Korea, Republic of, Spain, Australia, Germany, France, Japan, Canada
-
OBI Pharma, IncTerminatedLocally Advanced Solid TumorUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedLung Carcinoma | Lung Neoplasm | Malignant Lung NeoplasmUnited States
-
Memorial Sloan Kettering Cancer CenterCivaTech OncologyActive, not recruitingAbdominal Malignancy | Pelvic MalignancyUnited States
-
Memorial Sloan Kettering Cancer CenterStanford University; Juno Therapeutics, Inc.Active, not recruiting
-
Memorial Sloan Kettering Cancer CenterUniversity of Wisconsin, Madison; Duke University; AEterna ZentarisCompleted
-
Avenzo Therapeutics, Inc.Recruiting
-
Bristol-Myers SquibbTerminatedSolid TumorUnited States, Finland
-
Eli Lilly and CompanyTerminatedSolid TumorBelgium, United States, Japan
-
Herbert Irving Comprehensive Cancer CenterNational Cancer Institute (NCI)UnknownMalignant MesotheliomaUnited States
-
Multitude Therapeutics (Australia) Pty LtdRecruiting
-
PfizerMerck Sharp & Dohme LLCCompletedAdvanced Solid TumorsUnited States
-
Weill Medical College of Cornell UniversitySentire Medical SystemsRecruitingCrohn's Disease of Large Intestine | Malignant Neoplasm of ColonUnited States
-
MedImmune LLCCompletedSelect Advanced Solid TumorsUnited States, France, Netherlands
-
Eisai Inc.Completed
-
Roswell Park Cancer InstituteCompletedLung Cancer | Malignant MesotheliomaUnited States
-
University of SydneyUniversity of Roma La Sapienza; Australasian Bone Marrow Transplant Recipient... and other collaboratorsRecruiting
-
Roswell Park Cancer InstituteNovartisTerminatedRibociclib and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors or LymphomaLymphoma | Solid NeoplasmUnited States
-
Incyte CorporationRecruitingA Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid TumorsAdvanced Solid Tumors | Solid Tumors | Metastatic Solid TumorsUnited States, Spain, United Kingdom, France, Italy, Denmark, Switzerland
-
Calithera Biosciences, IncCompletedAdvanced Solid TumorsUnited States
-
Merck Sharp & Dohme LLCCompletedSolid NeoplasmsUnited States, Canada, Israel, Korea, Republic of
-
National Cancer Institute (NCI)Active, not recruitingHodgkin Lymphoma | Non-Hodgkin Lymphoma | Advanced Malignant Solid Neoplasm | Stage III Pancreatic Cancer AJCC v6 and v7 | Stage IV Pancreatic Cancer AJCC v6 and v7 | Metastatic Malignant Solid Neoplasm | Triple-Negative Breast Carcinoma | Unresectable Solid Neoplasm | Metastatic Malignant Neoplasm | Unresectable... and other conditionsUnited States
-
Vion PharmaceuticalsCompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Novartis PharmaceuticalsActive, not recruiting
-
Regeneron PharmaceuticalsSanofiCompletedSolid TumorsUnited States, Canada
-
Repare TherapeuticsDebiopharm International SARecruitingAdvanced Solid TumorUnited States, Canada, Denmark